Irish medical technology firm Medtronic has agreed to distribute artificial intelligence (AI)-based stroke care solutions provider Viz.ai’s new technology across US centres.
Viz.ai’s software, which holds US Food and Drug Administration (FDA) clearance, has been designed to detect suspected large vessel occlusion (LVO) strokes.
It can be linked to hospital computed tomography (CT) scanners and uses advanced deep learning to automatically notify specialists about a suspected LVO stroke.
